dihexa wiki | CAS 1401708-83-5 Dihexa | c-Met chemical |

[DOI] [PMC free article] [PubMed] [Google Scholar] 22.Niu M., Li Q., Zhang J., Wen F., Dang W., Duan G., Li H., Ruan W., Yang P., Guan C., et al

CD38 expression is absent on early hematopoietic progenitors, but variable and generally low on normal myeloid and lymphoid cells

Peptide drugs like tirzepatide are protein-based

According to the study of Chen, IncRNA NEAT1 induces sorafenib resistance of HCC patients through repressing miR-335 expression and activation of c-Met-Akt signaling pathway (Shao et al., 2015) and the combination of HGF and c-Met inhibitors and sorefenib could improve the efficacy of the first line systemic treatment ( In conclusion, although the tivantinib phase III trial failed and the reason is not clear, the role of c-Met inhibitors in treating HCC can not be denied